Delayed diagnosis and complications of Fanconi anaemia at advanced age - A paradigm

Kirsten Huck, Helmut Hanenberg, Sonja Gudowius, Roland Fenk, Reinhard Kalb, Kornelia Neveling, Beate Betz, Dieter Niederacher, Rainer Haas, Ulrich Göbel, Guido Kobbe, Detlev Schindler

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Fanconi anaemia (FA) is a rare recessive DNA repair disorder clinically characterised by congenital malformations, progressive bone marrow failure and a high propensity for developing malignancies at an early age, predominantly acute myeloid leukaemia (AML) and squamous cell carcinoma. It is conceivable that a number of patients with hypomorphic mutations are not diagnosed as FA until severe complications in the treatment of a malignancy occur. Here, we report on a patient with FA-A, diagnosed only at the age of 49 years due to persistent pancytopenia and myelodysplastic syndrome/AML induced by a first cycle of chemotherapy for bilateral metachronic breast cancer. This exceptional case clearly demonstrates that, in instances of long-lasting mild pancytopenia or development of malignancies, especially at an unusually young age, FA should be ruled out, irrespective of the patient's age and features, especially before inflicting severe genotoxic stress.

Original languageEnglish (US)
Pages (from-to)188-197
Number of pages10
JournalBritish Journal of Haematology
Volume133
Issue number2
DOIs
StatePublished - Apr 2006
Externally publishedYes

Fingerprint

Fanconi Anemia
Delayed Diagnosis
Pancytopenia
Acute Myeloid Leukemia
Neoplasms
Myelodysplastic Syndromes
Myeloid Cells
DNA Repair
DNA Damage
Squamous Cell Carcinoma
Bone Marrow
Breast Neoplasms
Drug Therapy
Mutation

Keywords

  • Breast cancer
  • Diagnosis
  • FANCA
  • Fanconi anaemia
  • Irradiation

ASJC Scopus subject areas

  • Hematology

Cite this

Huck, K., Hanenberg, H., Gudowius, S., Fenk, R., Kalb, R., Neveling, K., ... Schindler, D. (2006). Delayed diagnosis and complications of Fanconi anaemia at advanced age - A paradigm. British Journal of Haematology, 133(2), 188-197. https://doi.org/10.1111/j.1365-2141.2006.05998.x

Delayed diagnosis and complications of Fanconi anaemia at advanced age - A paradigm. / Huck, Kirsten; Hanenberg, Helmut; Gudowius, Sonja; Fenk, Roland; Kalb, Reinhard; Neveling, Kornelia; Betz, Beate; Niederacher, Dieter; Haas, Rainer; Göbel, Ulrich; Kobbe, Guido; Schindler, Detlev.

In: British Journal of Haematology, Vol. 133, No. 2, 04.2006, p. 188-197.

Research output: Contribution to journalArticle

Huck, K, Hanenberg, H, Gudowius, S, Fenk, R, Kalb, R, Neveling, K, Betz, B, Niederacher, D, Haas, R, Göbel, U, Kobbe, G & Schindler, D 2006, 'Delayed diagnosis and complications of Fanconi anaemia at advanced age - A paradigm', British Journal of Haematology, vol. 133, no. 2, pp. 188-197. https://doi.org/10.1111/j.1365-2141.2006.05998.x
Huck, Kirsten ; Hanenberg, Helmut ; Gudowius, Sonja ; Fenk, Roland ; Kalb, Reinhard ; Neveling, Kornelia ; Betz, Beate ; Niederacher, Dieter ; Haas, Rainer ; Göbel, Ulrich ; Kobbe, Guido ; Schindler, Detlev. / Delayed diagnosis and complications of Fanconi anaemia at advanced age - A paradigm. In: British Journal of Haematology. 2006 ; Vol. 133, No. 2. pp. 188-197.
@article{45e9d4b78c7e4bce9ddbeb2f10620216,
title = "Delayed diagnosis and complications of Fanconi anaemia at advanced age - A paradigm",
abstract = "Fanconi anaemia (FA) is a rare recessive DNA repair disorder clinically characterised by congenital malformations, progressive bone marrow failure and a high propensity for developing malignancies at an early age, predominantly acute myeloid leukaemia (AML) and squamous cell carcinoma. It is conceivable that a number of patients with hypomorphic mutations are not diagnosed as FA until severe complications in the treatment of a malignancy occur. Here, we report on a patient with FA-A, diagnosed only at the age of 49 years due to persistent pancytopenia and myelodysplastic syndrome/AML induced by a first cycle of chemotherapy for bilateral metachronic breast cancer. This exceptional case clearly demonstrates that, in instances of long-lasting mild pancytopenia or development of malignancies, especially at an unusually young age, FA should be ruled out, irrespective of the patient's age and features, especially before inflicting severe genotoxic stress.",
keywords = "Breast cancer, Diagnosis, FANCA, Fanconi anaemia, Irradiation",
author = "Kirsten Huck and Helmut Hanenberg and Sonja Gudowius and Roland Fenk and Reinhard Kalb and Kornelia Neveling and Beate Betz and Dieter Niederacher and Rainer Haas and Ulrich G{\"o}bel and Guido Kobbe and Detlev Schindler",
year = "2006",
month = "4",
doi = "10.1111/j.1365-2141.2006.05998.x",
language = "English (US)",
volume = "133",
pages = "188--197",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Delayed diagnosis and complications of Fanconi anaemia at advanced age - A paradigm

AU - Huck, Kirsten

AU - Hanenberg, Helmut

AU - Gudowius, Sonja

AU - Fenk, Roland

AU - Kalb, Reinhard

AU - Neveling, Kornelia

AU - Betz, Beate

AU - Niederacher, Dieter

AU - Haas, Rainer

AU - Göbel, Ulrich

AU - Kobbe, Guido

AU - Schindler, Detlev

PY - 2006/4

Y1 - 2006/4

N2 - Fanconi anaemia (FA) is a rare recessive DNA repair disorder clinically characterised by congenital malformations, progressive bone marrow failure and a high propensity for developing malignancies at an early age, predominantly acute myeloid leukaemia (AML) and squamous cell carcinoma. It is conceivable that a number of patients with hypomorphic mutations are not diagnosed as FA until severe complications in the treatment of a malignancy occur. Here, we report on a patient with FA-A, diagnosed only at the age of 49 years due to persistent pancytopenia and myelodysplastic syndrome/AML induced by a first cycle of chemotherapy for bilateral metachronic breast cancer. This exceptional case clearly demonstrates that, in instances of long-lasting mild pancytopenia or development of malignancies, especially at an unusually young age, FA should be ruled out, irrespective of the patient's age and features, especially before inflicting severe genotoxic stress.

AB - Fanconi anaemia (FA) is a rare recessive DNA repair disorder clinically characterised by congenital malformations, progressive bone marrow failure and a high propensity for developing malignancies at an early age, predominantly acute myeloid leukaemia (AML) and squamous cell carcinoma. It is conceivable that a number of patients with hypomorphic mutations are not diagnosed as FA until severe complications in the treatment of a malignancy occur. Here, we report on a patient with FA-A, diagnosed only at the age of 49 years due to persistent pancytopenia and myelodysplastic syndrome/AML induced by a first cycle of chemotherapy for bilateral metachronic breast cancer. This exceptional case clearly demonstrates that, in instances of long-lasting mild pancytopenia or development of malignancies, especially at an unusually young age, FA should be ruled out, irrespective of the patient's age and features, especially before inflicting severe genotoxic stress.

KW - Breast cancer

KW - Diagnosis

KW - FANCA

KW - Fanconi anaemia

KW - Irradiation

UR - http://www.scopus.com/inward/record.url?scp=33645091213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645091213&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2006.05998.x

DO - 10.1111/j.1365-2141.2006.05998.x

M3 - Article

C2 - 16611311

AN - SCOPUS:33645091213

VL - 133

SP - 188

EP - 197

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -